Matthew J. Giacalone

Toxic Protein Expression in <i>Escherichia Coli</i> Using a Rhamnose-Based Tightly Regulated and Tunable Promoter System

Matthew J. Giacalone, Angela Gentile, Brian T. Lovitt et al. · BioTechniques · 2006 · 174 citations · Full text

Preclinical evaluation of VAX-IP, a novel bacterial minicell-based biopharmaceutical for nonmuscle invasive bladder cancer

Shingo Tsuji, Xuguang Chen, Bryan Hancock et al. · Molecular Therapy — Oncolytics · 2016 · 22 citations · Full text

Antibiotic Adjuvant, Pharmacotherapy, Antimicrobial Chemotherapy +18

Immunization with non-replicating E. coli minicells delivering both protein antigen and DNA protects mice from lethal challenge with lymphocytic choriomeningitis virus

Matthew J. Giacalone, Juan Carlos Zapata, Neil L. Berkley et al. · Vaccine · 2007 · 18 citations · Full text

Vaccination, Mucosal Vaccination, Vaccine Development +12

A Single Intravesical Instillation of VAX014 Inhibits Orthotopic Superficial Bladder Tumor Implantation to Increase Survival

Bryan Hancock, Kathleen L. McGuire, Shingo Tsuji et al. · Anticancer Research · 2016 · 18 citations · Full text

The use of bacterial minicells to transfer plasmid DNA to eukaryotic cells

Matthew J. Giacalone, Angela Gentile, Brian T. Lovitt et al. · Cellular Microbiology · 2006 · 16 citations

Engineering, Bacteriology, Molecular Biology +17